Vendor, Athens, GA
Glycoscientific, L.L.C.
UEI EUVNNWGFCA87, CAGE 5CAT5
1 award and $0 obligated between April 29, 2024 and August 20, 2025, 100% under full and open competition, against 13.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00038Definitive Contract, April 29, 2024, Full and Open Competition After Exclusion of Sources, 13 offers | National Institutes of Health NiaidNational Institutes of Health | SBIR Topic 118: Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models.NAICS 541715, PSC AN11 | $0 |
- Places of performance
- Georgia
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards